• Investing
  • Stock
  • Editor’s Pick
  • Economy
The Significant Deals
Stock

MTU Aero Engines lifts 2024 earnings forecast on robust Q3 results

by October 15, 2024
written by October 15, 2024

On Tuesday, MTU Aero Engines (OTC:MTUAY) AG announced an increase in its earnings guidance for the financial year 2024. The company now anticipates an adjusted EBIT (earnings before interest and taxes) to exceed one billion euros. The previous forecast ranged between 0.95 and 0.98 billion euros. This revision reflects the company’s strong performance across all business sectors despite ongoing market challenges.

During the first three quarters of 2024, MTU Aero Engines AG reported preliminary adjusted revenues of 5.29 billion euros. The OEM (original equipment manufacturer) business segment contributed 1.79 billion euros to this figure, while the commercial maintenance segment accounted for 3.58 billion euros, before consolidation effects. As of September 2024, the adjusted EBIT stood at 744 million euros, translating to an EBIT margin of 14.0%. The OEM business segment delivered 444 million euros of the EBIT, with the remaining 300 million euros generated by commercial maintenance.

The company’s free cash flow was also noteworthy, reaching 213 million euros by the end of September. Despite the upward revision in earnings guidance, MTU Aero Engines AG has maintained its revenue and free cash flow forecasts for the year. Revenues are expected to be between 7.3 and 7.5 billion euros, and free cash flow is projected to be in the low triple-digit million euro range for 2024.

Investors and analysts can expect a comprehensive report on the company’s financial performance, as MTU Aero Engines AG is scheduled to release detailed financial figures for the first nine months of 2024 on October 24, 2024. This quarterly statement will provide further insights into the company’s financial health and operational success.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

This post appeared first on investing.com
0 comment
0
FacebookTwitterPinterestEmail

previous post
Citigroup shares rise as Q3 earnings, revenue top estimates
next post
PNC Financial quarterly profit drops on lower interest income, higher provisions

You may also like

BASF results down on impairments, restructuring

January 27, 2025

European chipmakers slump as traders gauge DeepSeek AI...

January 27, 2025

Nasdaq futures tumble as China’s AI push rattles...

January 27, 2025

China Vanke’s CEO, chairman resign amid growing liquidity...

January 27, 2025

Fuji Media, rocked by sexual misconduct allegations, says...

January 27, 2025

Italy’s MPS shares fall ahead of Mediobanca board...

January 27, 2025

British Land stock drops following stake sale

January 27, 2025

UMG shares rally after new multi-year pact with...

January 27, 2025

BASF shares indicated 3% lower as impairments drag...

January 27, 2025

Ryanair cuts 2026 traffic forecast amid ongoing Boeing...

January 27, 2025
Fill Out & Get More Relevant News








    Stay ahead of the market and unlock exclusive trading insights & timely news. We value your privacy - your information is secure, and you can unsubscribe anytime. Gain an edge with hand-picked trading opportunities, stay informed with market-moving updates, and learn from expert tips & strategies.

    Recent Posts

    • YouTube will stream NFL Week 1 game in Brazil for free

      May 15, 2025
    • 5 new Uber features you should know — including a way to avoid surge pricing

      May 15, 2025
    • American Eagle shares plunge 17% after it withdraws guidance, writes off $75 million in inventory

      May 14, 2025
    • Fintech company Chime files for Nasdaq IPO

      May 14, 2025

    Categories

    • Economy (245)
    • Editor's Pick (3,646)
    • Investing (461)
    • Stock (6,426)

    Latest News

    • YouTube will stream NFL Week 1 game in Brazil for free
    • 5 new Uber features you should know — including a way to avoid surge pricing

    Popular News

    • Sana Biotech’s islet cell therapy shows promise in diabetes; shares surge 150% postmarket
    • Column-Financial conditions vs real rates – is Fed policy too tight or too loose? McGeever

    About The Significant deals

    • Privacy Policy
    • Terms & Conditions

    Copyright © 2025 thesignificantdeals.com | All Rights Reserved

    The Significant Deals
    • Investing
    • Stock
    • Editor’s Pick
    • Economy